Last 12 months
Inside the activity.
1 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2024 Filed May 20, 2024 20:26 UTC |
Patel KinnariSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 3,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-026871 · form4.xml · derivative · entry 9 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,970 Underlying: Common Stock · 3,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years. F1 · derivative.expiration_date: Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| May 14, 2024 Filed May 20, 2024 20:26 UTC |
Patel KinnariSee Remarks
|
Exercise / conversionCommon Stock | 5,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-026871 · form4.xml · nonDerivative · entry 2 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Represents RSUs initially granted on February 14, 2023. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| May 14, 2024 Filed May 20, 2024 20:26 UTC |
Patel KinnariSee Remarks
|
Exercise / conversionCommon Stock | 3,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-026871 · form4.xml · nonDerivative · entry 1 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents RSUs initially granted on February 14, 2022. One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| May 02, 2024 Filed May 20, 2024 20:39 UTC |
SOUTHWELL DAVID PDirector
|
GiftCommon Stock | 59,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-026884 · form4.xml · nonDerivative · entry 2 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By The David P. Southwell Irrevocable Trust Dtd 04/14/2024 Disclosed balance after: 113,124 F1 · price: The shares of common stock were transferred by the Reporting Person as a gift to The David P. Southwell Irrevocable Trust Dtd 04/14/2024. No funds were exchanged, and no sale of shares occurred in the transfer. Read SEC document |
| May 02, 2024 Filed May 20, 2024 20:39 UTC |
SOUTHWELL DAVID PDirector
|
GiftCommon Stock | 113,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-026884 · form4.xml · nonDerivative · entry 1 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,660 F1 · price: The shares of common stock were transferred by the Reporting Person as a gift to The David P. Southwell Irrevocable Trust Dtd 04/14/2024. No funds were exchanged, and no sale of shares occurred in the transfer. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 20:06 UTC |
Militello JohnSee Remarks
|
SaleCommon Stock | 833 | $22.87 | $19,050.71 |
DisclosureSEC source: 0001140361-24-021703 · form4.xml · nonDerivative · entry 1 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,406 F1 · security: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. F1 · kind: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 21:45 UTC |
SOUTHWELL DAVID PDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 29,624 | $4.34 Strike: $4.34 | $128,627.41 |
DisclosureSEC source: 0001140361-24-020127 · form4.xml · derivative · entry 7 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,624 shares Expires 2024-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option represents a right to purchase a total of 99,624 shares of the Issuer's Common Stock, which became fully vested and exercisable on January 4, 2018. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 21:45 UTC |
SOUTHWELL DAVID PDirector
|
SaleCommon Stock | 10,000 | $24.05 | $240,520.00 |
DisclosureSEC source: 0001140361-24-020127 · form4.xml · nonDerivative · entry 5 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,784 F4 · security: Shares were sold by the Reporting Person in order to cover certain tax obligations. F5 · price: Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.85 to $24.335. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 21:45 UTC |
SOUTHWELL DAVID PDirector
|
Exercise / conversionCommon Stock | 29,624 | $4.34 | $128,627.41 |
DisclosureSEC source: 0001140361-24-020127 · form4.xml · nonDerivative · entry 4 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents shares received upon exercise of Stock Options, which would otherwise expire in August 2024. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:45 UTC |
SOUTHWELL DAVID PDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 70,000 | $4.34 Strike: $4.34 | $303,940.00 |
DisclosureSEC source: 0001140361-24-020127 · form4.xml · derivative · entry 6 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,624 Underlying: Common Stock · 70,000 shares Expires 2024-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option represents a right to purchase a total of 99,624 shares of the Issuer's Common Stock, which became fully vested and exercisable on January 4, 2018. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:45 UTC |
SOUTHWELL DAVID PDirector
|
SaleCommon Stock | 10,284 | $25.16 | $258,704.30 |
DisclosureSEC source: 0001140361-24-020127 · form4.xml · nonDerivative · entry 3 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,160 F4 · security: Shares were sold by the Reporting Person in order to cover certain tax obligations. F3 · price: Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.155 to $25.17. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:45 UTC |
SOUTHWELL DAVID PDirector
|
SaleCommon Stock | 59,716 | $24.22 | $1,446,560.38 |
DisclosureSEC source: 0001140361-24-020127 · form4.xml · nonDerivative · entry 2 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,444 F4 · security: Shares were sold by the Reporting Person in order to cover certain tax obligations. F2 · price: Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.87 to $24.68. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:45 UTC |
SOUTHWELL DAVID PDirector
|
Exercise / conversionCommon Stock | 70,000 | $4.34 | $303,940.00 |
DisclosureSEC source: 0001140361-24-020127 · form4.xml · nonDerivative · entry 1 SOUTHWELL DAVID P · CIK 0001251553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents shares received upon exercise of Stock Options, which would otherwise expire in August 2024. Read SEC document |
| April 08, 2024 Filed Apr 11, 2024 00:39 UTC |
White Mark AndrewSee Remarks
|
SaleCommon Stock | 12,532 | $24.64 | $308,763.42 |
DisclosureSEC source: 0001140361-24-019167 · form4.xml · nonDerivative · entry 1 White Mark Andrew · CIK 0001973240 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,226 F1 · security: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 18:02 UTC |
Ondrey AaronChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 69,337 | $0.00 Strike: $26.72 | $0.00 |
DisclosureSEC source: 0001140361-24-017684 · form4.xml · derivative · entry 2 Ondrey Aaron · CIK 0001991078 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,337 Underlying: Common Stock · 69,337 shares Expires 2034-04-01 F2 · derivative.exercise_date: This option represents a right to purchase a total of 69,337 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on April 1, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 18:02 UTC |
Ondrey AaronChief Financial Officer
|
GrantCommon Stock | 46,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-017684 · form4.xml · nonDerivative · entry 1 Ondrey Aaron · CIK 0001991078 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,781 F1 · security: Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on April 1, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. F1 · shares: Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on April 1, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:58 UTC |
Makker GothamDirector
|
SaleCommon Stock | 274,000 | $28.43 | $7,790,943.40 |
DisclosureSEC source: 0001140361-24-015103 · form4.xml · nonDerivative · entry 1 Makker Gotham · CIK 0001726391 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Simran Investment Group Disclosed balance after: 365,912 F1 · ownership.nature: The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein. Read SEC document |
| March 21, 2024 Filed Mar 26, 2024 00:54 UTC |
Militello JohnSee Remarks
|
SaleCommon Stock | 2,490 | $28.10 | $69,978.96 |
DisclosureSEC source: 0001140361-24-015101 · form4.xml · nonDerivative · entry 5 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,239 F4 · security: The shares of common stock were sold by the Reporting Person in order to pay tax obligations in connection with the vesting of RSUs over the course of 2023. F4 · kind: The shares of common stock were sold by the Reporting Person in order to pay tax obligations in connection with the vesting of RSUs over the course of 2023. Read SEC document |
| March 21, 2024 Filed Jun 10, 2024 10:34 UTC Amendment |
Makker GothamDirector
|
SaleCommon Stock | 274,000 | $28.43 | $7,790,943.40 |
DisclosureSEC source: 0001140361-24-029438 · form4.xml · nonDerivative · entry 1 Makker Gotham · CIK 0001726391 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Simran Investment Group Disclosed balance after: 365,912 F1 · ownership.nature: The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:54 UTC |
Militello JohnSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $12.55 Strike: $12.55 | $125,500.00 |
DisclosureSEC source: 0001140361-24-011170 · form4.xml · derivative · entry 3 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, one-third of which became fully vested and exercisable on January 8, 2019, with the remaining two-thirds vesting in equal quarterly installments over the following two years. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:54 UTC |
Militello JohnSee Remarks
|
SaleCommon Stock | 10,000 | $29.85 | $298,450.00 |
DisclosureSEC source: 0001140361-24-011170 · form4.xml · nonDerivative · entry 2 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,517 F2 · price: Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.78 to $29.91. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:54 UTC |
Militello JohnSee Remarks
|
Exercise / conversionCommon Stock | 10,000 | $12.55 | $125,500.00 |
DisclosureSEC source: 0001140361-24-011170 · form4.xml · nonDerivative · entry 1 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents shares received upon exercise of a Stock Option. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 23:48 UTC |
Wilson MartinGeneral Counsel
|
SaleCommon Stock | 4,100 | $29.33 | $120,257.10 |
DisclosureSEC source: 0001140361-24-011168 · form4.xml · nonDerivative · entry 1 Wilson Martin · CIK 0001704342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,680 F1 · price: Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.33 to $29.37. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Militello JohnSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 24,545 | $0.00 Strike: $30.01 | $0.00 |
DisclosureSEC source: 0001140361-24-008888 · form4.xml · derivative · entry 3 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,545 Underlying: Common Stock · 24,545 shares Expires 2034-02-16 F5 · derivative.exercise_date: This option represents a right to purchase a total of 24,545 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Militello JohnSee Remarks
|
GrantCommon Stock | 8,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008888 · form4.xml · nonDerivative · entry 2 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,517 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F4 · security: Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Militello JohnSee Remarks
|
SaleCommon Stock | 3,238 | $29.84 | $96,615.44 |
DisclosureSEC source: 0001140361-24-008888 · form4.xml · nonDerivative · entry 1 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,195 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F2 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. F3 · shares: The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Wilson MartinGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 49,091 | $0.00 Strike: $30.01 | $0.00 |
DisclosureSEC source: 0001140361-24-008890 · form4.xml · derivative · entry 3 Wilson Martin · CIK 0001704342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,091 Underlying: Common Stock · 49,091 shares Expires 2034-02-16 F5 · derivative.exercise_date: This option represents a right to purchase a total of 49,091 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Wilson MartinGeneral Counsel
|
GrantCommon Stock | 16,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008890 · form4.xml · nonDerivative · entry 2 Wilson Martin · CIK 0001704342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,780 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F4 · security: Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Wilson MartinGeneral Counsel
|
SaleCommon Stock | 3,576 | $29.84 | $106,700.69 |
DisclosureSEC source: 0001140361-24-008890 · form4.xml · nonDerivative · entry 1 Wilson Martin · CIK 0001704342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,136 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F2 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. F3 · shares: The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Patel KinnariSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 98,183 | $0.00 Strike: $30.01 | $0.00 |
DisclosureSEC source: 0001140361-24-008889 · form4.xml · derivative · entry 5 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,183 Underlying: Common Stock · 98,183 shares Expires 2034-02-16 F6 · derivative.exercise_date: This option represents a right to purchase a total of 98,183 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Patel KinnariSee Remarks
|
GrantCommon Stock | 33,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008889 · form4.xml · nonDerivative · entry 2 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,634 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F4 · security: Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Patel KinnariSee Remarks
|
SaleCommon Stock | 7,132 | $29.84 | $212,804.62 |
DisclosureSEC source: 0001140361-24-008889 · form4.xml · nonDerivative · entry 1 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,346 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F2 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. F3 · shares: The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
White Mark AndrewChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 32,727 | $0.00 Strike: $30.01 | $0.00 |
DisclosureSEC source: 0001140361-24-008887 · form4.xml · derivative · entry 2 White Mark Andrew · CIK 0001973240 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,727 Underlying: Common Stock · 32,727 shares Expires 2034-02-16 F2 · derivative.exercise_date: This option represents a right to purchase a total of 32,727 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
White Mark AndrewChief Medical Officer
|
GrantCommon Stock | 11,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008887 · form4.xml · nonDerivative · entry 1 White Mark Andrew · CIK 0001973240 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,758 F1 · security: Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. F1 · shares: Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Shah GauravDirector · CEO
|
GrantStock Option (Right to Buy) · Derivative | 196,336 | $0.00 Strike: $30.01 | $0.00 |
DisclosureSEC source: 0001140361-24-008886 · form4.xml · derivative · entry 5 Shah Gaurav · CIK 0001725922 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,336 Underlying: Common Stock · 196,336 shares Expires 2034-02-16 F5 · derivative.exercise_date: This option represents a right to purchase a total of 196,336 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Shah GauravDirector · CEO
|
GrantCommon Stock | 66,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008886 · form4.xml · nonDerivative · entry 2 Shah Gaurav · CIK 0001725922 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 621,339 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F4 · security: Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 16, 2024 Filed Feb 22, 2024 01:54 UTC |
Shah GauravDirector · CEO
|
SaleCommon Stock | 20,272 | $29.84 | $604,875.94 |
DisclosureSEC source: 0001140361-24-008886 · form4.xml · nonDerivative · entry 1 Shah Gaurav · CIK 0001725922 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554,762 F1 · security: The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the "Lock-Up Agreement"). F2 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. F3 · shares: The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Militello JohnSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008357 · form4.xml · derivative · entry 3 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,159 Underlying: Common Stock · 5,549 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years. F4 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Militello JohnSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008357 · form4.xml · derivative · entry 2 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,903 Underlying: Common Stock · 725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years. F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Militello JohnSee Remarks
|
Exercise / conversionCommon Stock | 6,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008357 · form4.xml · nonDerivative · entry 1 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Shah GauravDirector · CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 38,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008359 · form4.xml · derivative · entry 5 Shah Gaurav · CIK 0001725922 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,468 Underlying: Common Stock · 38,849 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years. F4 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Shah GauravDirector · CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008359 · form4.xml · derivative · entry 4 Shah Gaurav · CIK 0001725922 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,919 Underlying: Common Stock · 7,979 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years. F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Shah GauravDirector · CEO
|
Exercise / conversionCommon Stock | 46,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008359 · form4.xml · nonDerivative · entry 1 Shah Gaurav · CIK 0001725922 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 575,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Patel KinnariSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 22,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008358 · form4.xml · derivative · entry 5 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,268 Underlying: Common Stock · 22,199 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal annual installments over the following two years. F5 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal annual installments over the following two years. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Patel KinnariSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 3,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008358 · form4.xml · derivative · entry 4 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,960 Underlying: Common Stock · 3,990 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years. F4 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal annual installments over the following two years. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Patel KinnariSee Remarks
|
Exercise / conversionCommon Stock | 26,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008358 · form4.xml · nonDerivative · entry 1 Patel Kinnari · CIK 0001725929 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Wilson MartinGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 9,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008360 · form4.xml · derivative · entry 2 Wilson Martin · CIK 0001704342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,367 Underlying: Common Stock · 9,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years. F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:05 UTC |
Wilson MartinGeneral Counsel
|
Exercise / conversionCommon Stock | 9,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-008360 · form4.xml · nonDerivative · entry 1 Wilson Martin · CIK 0001704342 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. F1 · shares: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 21:22 UTC |
Militello JohnSee Remarks
|
SaleCommon Stock | 638 | $27.20 | $17,355.51 |
DisclosureSEC source: 0001140361-24-003421 · form4.xml · nonDerivative · entry 1 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,159 F1 · kind: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. F2 · kind: The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement. Read SEC document |
| January 18, 2024 Filed Jan 22, 2024 21:05 UTC |
Militello JohnSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 1,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-003111 · form4.xml · derivative · entry 2 Militello John · CIK 0001662170 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,932 Underlying: Common Stock · 1,586 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years. F3 · derivative.expiration_date: One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.